John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$175M |
| 2 |
Kroger
KR
|
+$148M |
| 3 |
Elevance Health
ELV
|
+$122M |
| 4 |
EA
Electronic Arts
EA
|
+$120M |
| 5 |
Abbott
ABT
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$181M |
| 2 |
Halliburton
HAL
|
+$152M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
AGN
Allergan plc
AGN
|
+$124M |
| 5 |
AutoZone
AZO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.33% |
| 2 | Technology | 13.07% |
| 3 | Consumer Discretionary | 10.5% |
| 4 | Financials | 9.32% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Coca-Cola
KO
$392B
| $51.1M | 0.22% |
1,128,390
+1,065,410
| +1,692% | +$48.1M |
|
102
Mastercard
MA
$509B
| $51.1M | 0.22% |
580,260
+242,692
| +72% | +$23.2M |
|
|
103
PUT
Pfizer
PFE
$160B
| $51M | 0.22% |
1,525,560
+1,078,348
| +241% | +$34.4M |
|
104
Idexx Laboratories
IDXX
$43.9B
| $50.5M | 0.22% |
543,983
+154,955
| +40% | +$13.3M |
|
105
PUT
ExxonMobil
XOM
$679B
| $48.4M | 0.21% |
516,500
+239,500
| +86% | +$21.2M |
|
|
CPGX
106
DELISTED
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
| $48.3M | 0.21% |
1,893,804
+1,754,564
| +1,260% | +$44.7M |
|
107
Take-Two Interactive
TTWO
$44.8B
| $48.3M | 0.21% |
1,272,704
+450,752
| +55% | +$16.6M |
|
108
JetBlue
JBLU
$1.85B
| $47.9M | 0.21% |
2,890,566
+2,340,312
| +425% | +$43.5M |
|
|
109
Pfizer
PFE
$160B
| $47.3M | 0.2% |
1,415,383
-4,552,699
| -76% | -$145M |
|
110
Carnival Corporation Ltd
CCL
$35.2B
| $47.2M | 0.2% |
1,068,574
+1,037,370
| +3,324% | +$50.9M |
|
111
Ametek
AME
$54.9B
| $47.1M | 0.2% |
1,019,006
+395,689
| +63% | +$19M |
|
|
112
CALL
Pfizer
PFE
$160B
| $47M | 0.2% |
1,405,825
+1,033,763
| +278% | +$33M |
|
113
Agilent Technologies
A
$44.9B
| $46.9M | 0.2% |
1,057,350
+324,231
| +44% | +$14M |
|
114
Workday
WDAY
$49.4B
| $46.9M | 0.2% |
627,670
+349,162
| +125% | +$26.6M |
|
115
Southwest Airlines
LUV
$19.8B
| $46.8M | 0.2% |
1,192,374
-34,140
| -3% | -$1.46M |
|
116
ConocoPhillips
COP
$162B
| $46.5M | 0.2% |
+1,065,834
| New | +$47M |
|
|
DNKN
117
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $46.2M | 0.2% |
1,058,875
+754,755
| +248% | +$34.5M |
|
118
Healthpeak Properties
DOC
$14.8B
| $45.7M | 0.2% |
+1,418,103
| New | +$44M |
|
119
Steel Dynamics
STLD
$32.8B
| $45.5M | 0.2% |
1,857,007
+740,831
| +66% | +$18.1M |
|
120
Iron Mountain
IRM
$36.3B
| $45.3M | 0.19% |
1,138,273
+1,020,914
| +870% | +$37.2M |
|
121
Veeva Systems
VEEV
$40.3B
| $44.8M | 0.19% |
+1,313,053
| New | +$39M |
|
122
Estee Lauder
EL
$36.9B
| $43.9M | 0.19% |
482,429
+311,155
| +182% | +$29M |
|
123
Herbalife
HLF
$1.33B
| $43.3M | 0.19% |
1,479,986
-164,552
| -10% | -$4.93M |
|
|
IHS
124
DELISTED
IHS INC CL-A COM STK
IHS
| $42.6M | 0.18% |
368,251
+146,704
| +66% | +$17.6M |
|
125
Masco
MAS
$14.5B
| $42.5M | 0.18% |
1,374,887
-819,235
| -37% | -$25.8M |
|
Similar funds
John Overdeck's Q2 2016 Portfolio in Review
As of Q2 2016, John Overdeck held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $2B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.
- John Overdeck's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
- John Overdeck added most to Nike in Q2 2016, an estimated $175M increase.
- John Overdeck's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
- John Overdeck fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $181M.
- John Overdeck's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
- John Overdeck opened 779 new positions and closed 661 in Q2 2016.
- John Overdeck's portfolio value rose 11% quarter-over-quarter to $23.3B.
Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.